2022
DOI: 10.1021/jacsau.2c00537
|View full text |Cite
|
Sign up to set email alerts
|

Design and Synthesis of Neutralizable Fondaparinux

Abstract: Fondaparinux, a clinically approved anticoagulant pentasaccharide for the treatment of thrombotic diseases, displays better efficacy and biosafety than other heparin-based anticoagulant drugs. However, there is no suitable antidote available for fondaparinux to efficiently manage its potential bleeding risks, thereby precluding its widespread use. Herein, we describe a convergent and stereocontrolled approach to efficiently synthesize an aminopentyl-functionalized pentasaccharide, which is further used to prep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

1
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 50 publications
1
10
0
Order By: Relevance
“…It was noteworthy that the pH of the reaction was maintained by slow addition of 1 M NaOH solution. The NMR data and high-resolution mass spectra (HRMS) of the synthetic 1 were identical to those reported in the literature for fondaparinux …”
supporting
confidence: 66%
See 2 more Smart Citations
“…It was noteworthy that the pH of the reaction was maintained by slow addition of 1 M NaOH solution. The NMR data and high-resolution mass spectra (HRMS) of the synthetic 1 were identical to those reported in the literature for fondaparinux …”
supporting
confidence: 66%
“…By the early 1980s, a unique pentasaccharide domain of heparin was found to be clinically effective; 20 years later, fondaparinux ( 1 , Arixtra), a structurally homogeneous pentasaccharide, was clinically approved as an alternative of heparin to treat thrombotic events . Compared with heparin and low-molecular weight heparin, fondaparinux is industrially obtained by chemical synthesis, and exhibits a longer half-life and better antithrombotic efficacy and biosafety . Over the past few decades, many glycosylation methods and strategies have been applied to the synthesis of heparin fragments and relevant oligosaccharides .…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The chemical synthesis of 1 remains challenging due to the requirement of the efficient preparation of multiple higher-carbon sugar building blocks such as l , d -Hep, d , d -Hep, and Kdo, as well as the stereoselective construction of glycosidic bonds. It was assumed that protected hexasaccharide would be synthesized through a convergent and stereocontrolled [3 + 3] method from appropriately protected monosaccharide building blocks 7 – 12 . The ability to selectively remove orthogonal protecting groups 2-naphthylmethyl (Nap) , and levulinoyl (Lev) , as the corresponding acceptors makes it possible to glycosylate the C4 position of the l , d -Hep residue and the C6 position of the glucose (Glc) residue, respectively. Furthermore, anomeric methyl glycoside can be selectively converted to hemiacetals for the preparation of glycosyl donors for glycosylations.…”
mentioning
confidence: 99%
“…Benzylation of the C6 hydroxyl of 17 with benzyl bromide (BnBr), NaH, and catalytic tetrabutylammonium iodide (TBAI) gave compound 8 . Cleavage of the Nap ether of 8 utilizing 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in a mixture solution of dichloromethane (DCM) and phosphate buffer (PBS, pH 7.4) without impacting other protecting groups , provided glycosyl acceptor 18 , which was coupled with thioglycoside donor 7 using N -iodosuccinimide (NIS) and trimethylsilyl trifluoromethanesulfonate (TMSOTf) to form β-linked disaccharide 19 ( J H1–H2 = 8.1 Hz) due to the neighboring-group participation effect of 2- O -Bz. The treatment of 19 with 80% acetic acid (AcOH) in water for the cleavage of isopropylidene acetals gave a 2,3-diol intermediate, followed by acylation with benzoyl chloride (BzCl) in pyridine to afford compound 20 .…”
mentioning
confidence: 99%